Search results for "Pulmonary hypertension"

showing 10 items of 125 documents

Pulmonary Hypertension and Thromboembolic Disease

2008

Pulmonary hypertension (PH) is a disease group that includes a wide variety of entities leading to an increased pulmonary arterial pressure. This chapter describes the basic mechanisms that lead to PH and the possibilities of MRI in diagnosing different aspects. A MR imaging protocol is provided making MRI a comprehensive modality for the classification of the underlying disease and assessment of hemodynamics.

medicine.medical_specialtybusiness.industryHemodynamicsDiseasePulmonary arterial pressuremedicine.diseasePulmonary hypertensionMr imagingUnderlying diseaseInternal medicinemedicine.arterymedicineCardiologyThromboembolic diseasebusinessBronchial artery
researchProduct

Chronic Thromboembolic Pulmonary Hypertension: Results From A Prospective, Observational European Registry

2010

medicine.medical_specialtybusiness.industryInternal medicineMedicineChronic thromboembolic pulmonary hypertensionObservational studybusinessA57. CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: DIAGNOSIS, TREATMENT, AND PATHOGENESIS
researchProduct

P2772The rule-out criteria for chronic thromboembolic pulmonary hypertension can identify patients without haemodynamic abnormalities and functional …

2019

Abstract Background Up to one-third of patients report persisting hemodynamic abnormalities and functional limitation over long-term follow-up after acute pulmonary embolism (PE). Purpose We tested whether a validated algorithm designed to rule-out chronic thromboembolic pulmonary hypertension (CTEPH) after acute PE can be used for identifying patients at lower risk of presenting with persisting symptoms and echocardiographic abnormalities. Methods The multicentre Follow-up of Acute Pulmonary Embolism (FOCUS) cohort study prospectively enrolled 1,100 consecutive patients diagnosed with acute symptomatic PE; two-year follow-up is ongoing. We focused on the scheduled visits for 3- and 12-mont…

medicine.medical_specialtybusiness.industryInternal medicinemedicineCardiologyHemodynamicsChronic thromboembolic pulmonary hypertensionCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Pulmonale Thrombendarteriektomie bei thromboembolischer pulmonaler Hypertonie: Indikationen und Frühergebnisse

2008

Pulmonary thrombendarterectomy was performed in 32 patients (14 men and 18 women; mean age 38 +/- 15 years) with thromboembolic pulmonary hypertension (New York Heart Association stage III: n = 22; stage IV: n = 10). The preoperative arterial pO2 averaged 59 +/- 11 mm Hg; pulmonary vascular resistance (PVR) and mean pressure (MPAP) were increased to 1,045 +/- 430 dyn.s.cm-5 and 53 +/- 12 mm Hg, respectively. The perioperative death rate was 22% (7 of 32). In the 25 survivors the pulmonary hypertension was reduced to a PVR of 194 +/- 75 dys.s.cm-5, MPAP of 28 +/- 6 mm Hg. Subsequent re-examination in 15 patients (NYHA stage I: n = 14, stage II: n = 1) after a mean of 17 +/- 5 months demonstr…

medicine.medical_specialtybusiness.industryMean pressureGeneral MedicineStage iimedicine.diseasePulmonary hypertensionNew york heart associationmedicine.anatomical_structureEarly resultsInternal medicineVascular resistancemedicineCardiologyStage (cooking)businessThromboembolic pulmonary hypertensionDMW - Deutsche Medizinische Wochenschrift
researchProduct

P2540Sex-specific differences in the clinical presentation, surgical complications, and course of chronic thromboembolic pulmonary hypertension

2019

Abstract Background Women are more susceptible to develop several forms of pulmonary hypertension, but they may have better survival rates than men. Sparse data are available concerning sex-specific differences in chronic thromboembolic pulmonary hypertension (CTEPH). Purpose and methods We investigated sex-specific differences in the clinical presentation of CTEPH, functional parameters, exposure to pulmonary endarterectomy (PEA), and survival. Results Women constituted half of the study population (N=679 treatment-naïve patients from the European CTEPH registry) and were characterized by a lower prevalence of some cardiovascular risk factors (e.g. prior acute coronary syndrome, smoking ha…

medicine.medical_specialtybusiness.industryMedicineChronic thromboembolic pulmonary hypertensionPresentation (obstetrics)Cardiology and Cardiovascular MedicinebusinessIntensive care medicineEuropean Heart Journal
researchProduct

Hiatal herniation of the stomach and pancreas in a patient with oxygen desaturations

2013

Hiatal hernia (HH), a neglected cause of cardiorespiratory symptoms, is a frequent entity characterized by the displacement of the gastro- esophageal junction and part of the stomach into the mediastinum. Although often asymptomatic, HH may also exert a wide spectrum of clinical presentations due to cardio-pulmonary compression, including acute cardiovascular events such as arrhythmias, post-prandial syncope, angina-like chest pain, recurrent acute heart failure, hemodynamic collapse, electrocardiographic changes (T-wave inversion, ST elevation) simulating myocardial ischemia or pericarditis, and respiratory manifestations that can range from exercise intolerance and dyspnea on exertion to …

medicine.medical_specialtybusiness.industryST elevationGeneral MedicineExercise intolerancemedicine.diseaseChest painAsymptomaticPulmonary function testingHiatal hernia ;respiratory desaturation ; pancreas; pulmonary hypertensionHiatal herniaPericarditisHeart failureInternal medicineCardiologyMedicineMedicinecardiovascular diseasesmedicine.symptombusinessLetter to the EditorThe Libyan Journal of Medicine
researchProduct

The Prognostic Role of Hypertrabeculation By Cardiac Magnetic Resonance in Thalassemia Intermedia Patients

2016

Abstract Background. Differentiation of left ventricle non-compaction (LVNC) from hypertrabeculated LV due to a negative heart remodeling in thalassemia intermedia (TI) can depends on the selected CMR criterion. The recently proposed Piga's criterion (NC/C ratio threshold of >2.5, Am J Haem 2012) seems to have a low specificity to identify the true LVNC in TI. Anyway, the Piga's criterion could well detect easy a negative heart remodeling in TI patients. Purpose: To assess prospectively whether the Piga's criterion has a prognostic role for adverse cardiovascular outcomes in TI patients. Methods. We studied prospectively by CMR 168 TI patients (81 males, mean age 38.32 ±11.61 years) cons…

medicine.medical_specialtybusiness.industryThalassemiaImmunologyCardiac arrhythmiaCell BiologyHematology030204 cardiovascular system & hematologymedicine.diseaseBiochemistryPulmonary hypertensionSurgery03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureVentricleHeart failureInternal medicinemedicineCardiologyPopulation study030212 general & internal medicineThalassemia intermediabusinessCardiac magnetic resonanceBlood
researchProduct

Chronische thromboembolische pulmonale Hypertonie: Hämodynamische Auswirkungen der selektiven Pulmonalis-DSA mit nicht-ionischem Kontrastmittel

1998

PURPOSE This study evaluates the effects of pulmonary bolus injection of nonionic contrast medium on pulmonary artery pressure and resistance in patients with chronic thromboembolic pulmonary hypertension. METHODS In 39 patients (age 52 +/- 15) haemodynamic measurements were performed during bolus injection of nonionic contrast medium in a control group (I), in moderately severe (II) and severe pulmonary hypertension (III). RESULTS Initial inspiratory arrest caused significant pressure increase in all groups prior to bolus injection (delta PAsyst: 7.1 +/- 6.7 [I], 6.8 +/- 3.9 [II] und 7.2 +/- 7.9 mmHg p < 0.05). However, contrast bolus injection (25.1 +/- 2.3 ml iopamidol, 13.0 ml/s) caused…

medicine.medical_specialtybusiness.industryVascular diseaseRespiratory diseaseHemodynamicsmedicine.diseasePulmonary hypertensionIopamidolSurgeryContrast mediummedicine.anatomical_structureInternal medicinemedicine.arteryPulmonary arterymedicineCardiologyVascular resistanceRadiology Nuclear Medicine and imagingbusinessmedicine.drugRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Effects of Tolazoline and Prostacyclin on Pulmonary Hypertension in Infants After Cardiac Surgery

1992

Objective To evaluate the hemodynamic effects of tolazoline and prostacyclin in infants with pulmonary vasospasm after cardiac surgery. Design Prospective cohort study. Setting Pediatric ICU. Patients The cohort consisted of 42 infants and children with congenital heart disease and pulmonary hypertension who underwent corrective surgery and were monitored postoperatively using pulmonary artery catheters. Fourteen infants (2 to 12 months old) in this group required postoperative treatment with tolazoline or prostacyclin. Interventions Tolazoline was administered as a bolus of 0.5 mg/kg for treatment of persistent pulmonary hypertension or acute pulmonary hypertensive crisis. If its effective…

medicine.medical_specialtybusiness.industryVasospasmProstacyclinCritical Care and Intensive Care Medicinemedicine.diseasePulmonary hypertensionCardiac surgerymedicine.anatomical_structureBolus (medicine)medicine.arteryAnesthesiaInternal medicinePulmonary arteryVascular resistancemedicineCardiologyTolazolinebusinessmedicine.drugSurvey of Anesthesiology
researchProduct

Chronisch thromboembolische pulmonale Hypertonie: Empfehlungen der Kölner Konsensus Konferenz 2016

2016

The 2015 European Guidelines on Pulmonary Hypertension did not cover only pulmonary arterial hypertension (PAH), but also other significant subgroups of pulmonary hypertension (PH). In June 2016, a Consensus Conference organized by the PH working groups of the German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Pediatric Cardiology (DGPK) was held in Cologne, Germany to discuss open and controversial issues surrounding the practical implementation of the European Guidelines. Several working groups were initiated, one of which was dedicated to the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (CTEPH). In ev…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentConsensus conference610 Medicine & health2700 General MedicineGeneral Medicine030204 cardiovascular system & hematologymedicine.diseasePulmonary hypertension3. Good healthPulmonary endarterectomy03 medical and health sciences0302 clinical medicinePharmacotherapy030228 respiratory systemAngioplastymedicine.arteryPulmonary arterymedicineChronic thromboembolic pulmonary hypertension10178 Clinic for PneumologyIntensive care medicinebusinessPediatric cardiologyDMW - Deutsche Medizinische Wochenschrift
researchProduct